Ryan Walsh

2.5k total citations
33 papers, 1.2k citations indexed

About

Ryan Walsh is a scholar working on Molecular Biology, Pharmacology and Computational Theory and Mathematics. According to data from OpenAlex, Ryan Walsh has authored 33 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 14 papers in Pharmacology and 10 papers in Computational Theory and Mathematics. Recurrent topics in Ryan Walsh's work include Cholinesterase and Neurodegenerative Diseases (14 papers), Computational Drug Discovery Methods (10 papers) and Advanced biosensing and bioanalysis techniques (8 papers). Ryan Walsh is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (14 papers), Computational Drug Discovery Methods (10 papers) and Advanced biosensing and bioanalysis techniques (8 papers). Ryan Walsh collaborates with scholars based in Canada, United States and Germany. Ryan Walsh's co-authors include Earl Martin, Sultan Darvesh, Maria C. DeRosa, Katherine Valenta Darvesh, Robert McDonald, Kenneth Rockwood, Sheila Roberts, Yanina Shevchenko, David A. Blair and Jacques Albert and has published in prestigious journals such as PLoS ONE, Analytical Chemistry and Analytical Biochemistry.

In The Last Decade

Ryan Walsh

33 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryan Walsh Canada 20 514 407 243 232 217 33 1.2k
Devendra Kumar India 17 222 0.4× 227 0.6× 212 0.9× 245 1.1× 129 0.6× 76 893
Githa Elizabeth Mathew India 26 443 0.9× 704 1.7× 271 1.1× 248 1.1× 162 0.7× 48 1.7k
Liang Wu China 23 761 1.5× 175 0.4× 84 0.3× 189 0.8× 220 1.0× 56 1.2k
Dennis O. Scott United States 26 638 1.2× 560 1.4× 273 1.1× 75 0.3× 188 0.9× 51 2.1k
Marina Naldi Italy 24 606 1.2× 352 0.9× 228 0.9× 47 0.2× 106 0.5× 73 1.5k
Paweł Szymański Poland 20 482 0.9× 448 1.1× 442 1.8× 36 0.2× 138 0.6× 86 1.6k
Елена В. Рудакова Russia 20 347 0.7× 674 1.7× 455 1.9× 58 0.3× 89 0.4× 96 1.2k
Elżbieta Mikiciuk‐Olasik Poland 23 711 1.4× 328 0.8× 312 1.3× 28 0.1× 134 0.6× 78 1.8k
Meicun Yao China 23 639 1.2× 188 0.5× 43 0.2× 188 0.8× 135 0.6× 91 1.5k
İpek Baysal Türkiye 16 210 0.4× 312 0.8× 107 0.4× 116 0.5× 41 0.2× 45 829

Countries citing papers authored by Ryan Walsh

Since Specialization
Citations

This map shows the geographic impact of Ryan Walsh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan Walsh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan Walsh more than expected).

Fields of papers citing papers by Ryan Walsh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryan Walsh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan Walsh. The network helps show where Ryan Walsh may publish in the future.

Co-authorship network of co-authors of Ryan Walsh

This figure shows the co-authorship network connecting the top 25 collaborators of Ryan Walsh. A scholar is included among the top collaborators of Ryan Walsh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryan Walsh. Ryan Walsh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Walsh, Ryan, Mohamed Cherif, Hassan A. Hafez, et al.. (2021). High-sensitivity small-molecule detection of microcystin-LR cyano-toxin using a terahertz-aptamer biosensor. The Analyst. 146(24). 7583–7592. 8 indexed citations
2.
Tran, Nam K., Ryan Walsh, John V. Pepper, et al.. (2021). Novel application of automated machine learning with MALDI-TOF-MS for rapid high-throughput screening of COVID-19: a proof of concept. Scientific Reports. 11(1). 8219–8219. 59 indexed citations
3.
5.
Liu, Jun, et al.. (2016). Analysis of bacterial, fungal and archaeal populations from a municipal wastewater treatment plant developing an innovative aerobic granular sludge process. World Journal of Microbiology and Biotechnology. 33(1). 14–14. 45 indexed citations
6.
Walsh, Ryan, et al.. (2015). Enzyme-linked DNA dendrimer nanosensors for acetylcholine. Scientific Reports. 5(1). 14832–14832. 25 indexed citations
7.
Rockwood, Kenneth, Ryan Walsh, Earl Martin, & Sultan Darvesh. (2011). Potentially Procholinergic Effects of Medications Commonly Used in Older Adults. ˜The œAmerican journal of geriatric pharmacotherapy. 9(1). 80–87. 6 indexed citations
8.
Walsh, Ryan, Kenneth Rockwood, Earl Martin, & Sultan Darvesh. (2011). Synergistic inhibition of butyrylcholinesterase by galantamine and citalopram. Biochimica et Biophysica Acta (BBA) - General Subjects. 1810(12). 1230–1235. 23 indexed citations
9.
Holahan, Matthew R., Dan Madularu, Erin M. McConnell, Ryan Walsh, & Maria C. DeRosa. (2011). Intra-Accumbens Injection of a Dopamine Aptamer Abates MK-801-Induced Cognitive Dysfunction in a Model of Schizophrenia. PLoS ONE. 6(7). e22239–e22239. 17 indexed citations
10.
Darvesh, Sultan, Ian R. Pottie, Katherine Valenta Darvesh, et al.. (2010). Differential binding of phenothiazine urea derivatives to wild-type human cholinesterases and butyrylcholinesterase mutants. Bioorganic & Medicinal Chemistry. 18(6). 2232–2244. 35 indexed citations
11.
Walsh, Ryan & Maria C. DeRosa. (2009). Retention of function in the DNA homolog of the RNA dopamine aptamer. Biochemical and Biophysical Research Communications. 388(4). 732–735. 105 indexed citations
13.
Darvesh, Sultan, Katherine Valenta Darvesh, Robert McDonald, et al.. (2008). Carbamates with Differential Mechanism of Inhibition Toward Acetylcholinesterase and Butyrylcholinesterase. Journal of Medicinal Chemistry. 51(14). 4200–4212. 134 indexed citations
14.
Darvesh, Sultan, et al.. (2007). Selective reversible inhibition of human butyrylcholinesterase by aryl amide derivatives of phenothiazine. Bioorganic & Medicinal Chemistry. 15(19). 6367–6378. 51 indexed citations
15.
Walsh, Ryan, Earl Martin, & Sultan Darvesh. (2007). A versatile equation to describe reversible enzyme inhibition and activation kinetics: Modeling β-galactosidase and butyrylcholinesterase. Biochimica et Biophysica Acta (BBA) - General Subjects. 1770(5). 733–746. 19 indexed citations
16.
Darvesh, Sultan, Ryan Walsh, & Earl Martin. (2006). Homocysteine Thiolactone and Human Cholinesterases. Cellular and Molecular Neurobiology. 27(1). 33–48. 22 indexed citations
17.
Darvesh, Sultan, Robert McDonald, Katherine Valenta Darvesh, et al.. (2006). On the active site for hydrolysis of aryl amides and choline esters by human cholinesterases. Bioorganic & Medicinal Chemistry. 14(13). 4586–4599. 34 indexed citations
18.
Darvesh, Sultan, et al.. (2004). Structure–activity relationships for inhibition of human cholinesterases by alkyl amide phenothiazine derivatives. Bioorganic & Medicinal Chemistry. 13(1). 211–222. 53 indexed citations
19.
Darvesh, Sultan, Ryan Walsh, & Earl Martin. (2003). Enantiomer Effects of Huperzine A on the Aryl Acylamidase Activity of Human Cholinesterases. Cellular and Molecular Neurobiology. 23(1). 93–100. 9 indexed citations
20.
Darvesh, Sultan, Earl Martin, Ryan Walsh, & Kenneth Rockwood. (2003). Differential effects of lipid-lowering agents on human cholinesterases. Clinical Biochemistry. 37(1). 42–49. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026